C12N 2740/16033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2740/16033 (Use of viral protein as therapeutic agent other than vaccine) appears on 52 US grants and 75 published applications in this corpus.
Search patents in C12N- Granted patents
- 52
- Published applications
- 75
- Assignees
- 62
- Inventors
- 151
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 1 | 1 |
| 2012 | 0 | 2 |
| 2013 | 5 | 8 |
| 2014 | 2 | 6 |
| 2015 | 3 | 8 |
| 2016 | 5 | 12 |
| 2017 | 4 | 6 |
| 2018 | 4 | 3 |
| 2019 | 7 | 5 |
| 2020 | 2 | 2 |
| 2021 | 7 | 6 |
| 2022 | 4 | 5 |
| 2023 | 0 | 3 |
| 2024 | 3 | 1 |
| 2025 | 3 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating HIV infection and reversing HIV latency6 Jan 2026US 12,514,921 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Compositions for treating cancer14 Oct 2025US 12,440,564 B2Kelonia Therapeutics, Inc.
- Compositions for treating cancer2 Sep 2025US 12,403,194 B2Kelonia Therapeutics, Inc.
- Compositions and methods for treating SARS-CoV-2 infections7 Jan 2025US 12,187,767 B2Morehouse School of Medicine
- Immune cells with DNMT3A gene modifications and methods related thereto10 Dec 2024US 12,161,671 B2Emory University
- Compositions for treating cancer27 Mar 2025US 2025/0099587 A1Kelonia Therapeutics, Inc.
- Compositions for treating cancer27 Mar 2025US 2025/0099615 A1Kelonia Therapeutics, Inc.
- Simultaneous detection of antigens and antigen specific antibodies in a guinea pig model system27 Mar 2025US 2025/0102520 A1Vanderbilt University
- Engineered Antimicrobial Peptides and Usage Thereof26 Sep 2024US 2024/0317809 A1Peptilogics, Inc.
- Pharmaceutical compositions and anti-viral uses thereof22 Jun 2023US 2023/0190863 A1Code Pharma B.V.
Most cited
By later US patents
- Methods and compositions for inhibiting viral entry into cells22US 9,566,352 B2Sangamo BioSciences, Inc. · 2017
- Cell-penetrating compstatin analogs and uses thereof12US 10,308,687 B2Apellis Pharmaceuticals, Inc. · 2019
- Virus derived antimicrobial peptides12US 8,071,540 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2011
- Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles11US 8,431,530 B2Morehouse School of Medicine · 2013
- Compositions and methods for treating cancer by inhibiting the secretion of microparticles9US 8,476,237 B2Morehouse School of Medicine · 2013